DanielStermanMDFCCP ATSF DAABIP

Critical Care Medicine, Interventional Pulmonology, Pleural Disease, Thoracic Oncology

Thomas & Suzanne Murphy Professor of Pulmonary & Critical Care Medicine Director, Division of Pulmonary, Critical Care & Sleep Medicine Director, Multidisciplinary Pulmonary Oncology Program Departments of Medicine & Cardiothoracic Surgery NYU Langone Medical Center

Join to view full profile

Dr. Sterman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sterman's full profile

Already have an account?

Office
222 East 41st Street
21st Floor
New York, NY 10017

Education & Training

University of Pennsylvania Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 1993 - 1997
University of Pennsylvania Health SystemResidency, Internal Medicine, 1989 - 1992
Weill Cornell MedicineClass of 1989

Certifications & Licensure

NY State Medical License 2014 - 2026
PA State Medical License 1991 - 2016
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2010-2014
Philadelphia Magazine Castle Connolly, 2005-2006, 2010-2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
America's Top Doctors for Cancer Castle Connolly, 2010
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions Start of enrollment: 2003 Apr 01
Completed
Phase 1
Gene Therapy for Pleural Malignancies Start of enrollment: 2006 Mar 01
Completed
Phase 1
Combination Gene Transfer and Chemotherapy Start of enrollment: 2010 Apr 27
Completed
Phase 1
Intrapleural Gene Transfer for Pleural Mesothelioma Start of enrollment: 2009 Feb 01
Completed
Phase 1
Do Your Genes Put You at a Higher Risk of Developing Mesothelioma Start of enrollment: 2011 Jun 01
Completed
Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma Start of enrollment: 2019 Jan 21
Active, not recruiting
Phase 3
Bronchoscopic Cryo-Immunotherapy of Lung Cancer Start of enrollment: 2020 Feb 15
Recruiting
Early Phase 1
CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC Start of enrollment: 2020 Oct 13
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

59 citations
Evaluation of an Attenuated Vesicular Stomatitis Virus Vector Expressing Interferon-β for Use in Malignant Pleural Mesothelioma: Heterogeneity in Interferon Responsive...
Vassiliki Saloura, Liang Chuan S. Wang, Zvi G. Fridlender, Jing Sun, Guanjun Cheng
Human Gene Therapy. 2010-01-01
124 citations
Lower Airway Dysbiosis Affects Lung Cancer Progression.
Jun Chieh J. Tsay, Benjamin G. Wu, Imran Sulaiman, Katherine Gershner, R. Schluger
Cancer Discovery. 2021-02-01
279 citations
Tumors of the mediastinum.
Beau V. Duwe, Daniel H. Sterman, Ali I. Musani
Chest. 2005-10-01

Journal Articles

Airway Microbiota Is Associated with up-Regulation of the PI3K Pathway in Lung Cancer
Benjamin G Wu, Harvey Pass, William N Rom, Daniel H Sterman, Vivek Murthy, Martin J Blaser, Michael D Weiden, Leopoldo N Segal, ATS Journals

Other

Immunological Aspects of Cryoablation of Non-Small Cell Lung Cancer: A Comprehensive Review
Daniel Sterman, MD, Journal of Thoracic Oncology
https://www.doximity.com/articles/7d6dccf9-2812-48ac-a155-50f4bf605f29
UpToDate, Wolters Kluwer Health - 2013-01-16

Authored Content

Immunological Aspects of Cryoablation of Non-Small Cell Lung Cancer: A Comprehensive ReviewFebruary 2018

Press Mentions

Do I Have Long COVID? Here Is How to KnowJuly 20th, 2022
Do I Have Long COVID? Here’s How to TellJuly 19th, 2022
Candel Therapeutics Announces Release of Initial Data on CAN-2409 in a Phase 2 Clinical Trial Showing Cytotoxic T Cell Response and Disease Control in Patients with Non-Small Cell Lung CancerMay 26th, 2022
Join now to see all

Grant Support

Clinical Trials In MesotheliomaNational Cancer Institute2006–2010
Intrapleural Adenoviral-Mediated Interferon-Beta (Ifn-B) Gene TransferNational Center For Research Resources2005
Ifn-B Gene Transfer For Pleural MalignanciesNational Center For Research Resources2004
Upcc: Trial Of Intravenous Pv701 In PTS W Solid TumorsNational Center For Research Resources2000–2002
Upcc 5598: Gene Therapy Of Malignant Mesothelioma Using El/E4 Deleted AdenovirusNational Center For Research Resources2000–2002
Upcc#5597:A Phase I Trial Of El/E4 Deleted Ad.Rsvtk Virus W/ GanciclovirNational Center For Research Resources1999–2002
Gene Therapy Of Malignant Mesothelioma Using E1 Deleted AdenovirusNational Center For Research Resources1999–2000